Toro 71 Aspiration Catheter; Toro Aspiration Tubing
Toro Neurovascular, Inc. · Decision date Oct 21, 2026
What did the FDA decide?
FDA recorded a substantially equivalent decision for K262021 on 2026-10-21, covering the Toro 71 Aspiration Catheter and Toro Aspiration Tubing, submitted by Toro Neurovascular, Inc. The listing places the device under product code NRY with a Cardiovascular specialty. Substantially equivalent in the 510(k) pathway denotes clearance to market, not premarket approval of a new device.
The available record identifies the device and applicant but does not describe the predicate device, the specific component changes, or the intended use statement. The source excerpt also does not state whether the tubing is a separately cleared accessory or part of the same submission. Those details would require the underlying FDA decision document, which is not included here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 21, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262021
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Toro Neurovascular, Inc.
- Product code
- NRY
- Decision code
- SESE
- Decision date
- Oct 21, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Catheter, Thrombus Retriever.
- Applicant
- Toro Neurovascular, Inc.
- Product code
- NRY
- FDA device class
- 2
FDA decision timeline
K262021 received
Application receipt date recorded by FDA.
K262021 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code NRY
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Route 92 Medical, Inc. | 510(k) clearance | Oct 16, 2026 | FDA | |
| Maduro Medical, Inc. | 510(k) clearance | Sep 14, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Toro Neurovascular, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Irvine, CA
Sources and methodology
- Original FDA record: K262021
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
